Tvärvetenskaplig forskning om nanomedicinska precisionsterapier får 30 miljoner

30 miljoner till tvärvetenskapliga forskningsmiljöer tilldelas ett projekt om nanomedicinska precisionsterapier för behandling av nedre luftvägsinfektioner.

By Karin Winter

January 19, 2022 12:53 PM

Projektet syftar till att utveckla nanopartikelbaserade precisionsterapier för behandling av nedre luftvägsinfektioner. Infektionerna orsakas av gramnegativa och grampositiva bakterier, vilket inkluderar antibiotikaresistenta stammar och det gör att det finns ett stort behov av nya behandlingsformer.

1 month free trial

Get access to all content on Life Science Nordic

No commitment or card information required

Try Life Science Nordic now

Already a subscriber? Log In

Applies to personal subscription only.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.

Yes please, I would like to receive Life Science Nordics newsletter Read cookie and data policy.

Yes please, I would like to receive marketing, offers, surveys, etc. from Life Science Nordic Read cookie and data policy.

{{ window.visitor.corporateClient.name }}

Corporate solution

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}

Tvärvetenskaplig forskning om nanomedicinska precisionsterapier får 30 miljoner

“Ozempic babies” – myth or reality?

Hacker group claims Chinese bid for stolen Novo data

AstraZeneca scraps late‑stage study – and reports dual successes in lung cancer

Life Science Nordic launches – bringing Nordic life science news under one roof

Lantheus challenges Eli Lilly with FDA-approved Alzheimer’s tracer

Hansa chair: “Too many boards spend far too much time looking inwards”

ZEISS Innovation Summit returns to Berlin

Ensuring Safety and Compliance for IVD Products

100 000 timmar av beprövad tillförlitlighet: KNF:s membranpumpar sätter en ny standard

60 års expertis inom läcksökning: Pfeiffer Vacuum+Fab Solutions firar ett jubileum

From Complex Biology to Faster Decisions: Scalable 3D HCA for NAM-Driven Drug Discovery

QAdvis & Scandinavian CRO are now Aurevia

Experience fast and easy optical inspection

Strengthen your team with Clinical and Regulatory Experts

Clinical and regulatory expertise that delivers results

Medtech Compliance Forum by Aurevia & RAPS

Experienced clinical and regulatory support for a busy autumn

Expanding into the EU market?